(13-109) Evaluating the Potential Impacts of Opioid Use on the Incidence and Severity of Immune-Related Adverse Events in Oncology Patients Receiving Immune Checkpoint Inhibitors
Wednesday, December 10, 2025
3:15 PM - 4:15 PM
Location: Bayside A, Level 1
Residency Program: Baylor Scott & White Medical Center – Temple / Baylor Scott & White Health Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Texas
Co-Author(s): Caleb Castillo, Genevieve Hoffmann, Jessica Christian, Charlotte Farris
